Home › Funds › Siren, L.L.C. › RAPP

Siren, L.L.C. position in RAPP

Rapport Therapeutics, Inc. · Health Care

Siren, L.L.C. reported holding 641,469 shares of RAPP (Rapport Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$21.6M, representing 0.51% of its reported portfolio and ranking #47 among its reported holdings. Siren, L.L.C. has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)641.47K sh
Reported value held$21.55M
Portfolio Weight0.51%
First reportedQ3 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s RAPP position evolved

Siren, L.L.C. first disclosed a stake in RAPP in Q3 2024 at 384,197 shares (US$7.9M). The position peaked in Q3 2025 at 1,053,469 shares, worth US$31.3M. Across 9 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 641,469 shares valued at US$21.6M. Notable position changes include a 178% increase in Q3 2025 (shares rose 2% over the following quarter), a 33% trim in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 384.20K $7.87M New
Q4 2024 384.20K $6.82M Hold
Q1 2025 378.47K $3.80M Reduce
Q2 2025 378.47K $4.30M Hold
Q3 2025 1.05M $31.29M Add
Q4 2025 708.47K $21.49M Reduce
Q1 2026 641.47K $20.07M Reduce
Q2 2026 641.47K $26.73M Hold
Q3 2026 641.47K $21.55M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (Rapport Therapeutics, Inc.) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has Siren, L.L.C. held RAPP?

Siren, L.L.C. has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in RAPP?

As of Q3 2026, Siren, L.L.C. holds 641.47K shares of RAPP (Rapport Therapeutics, Inc.), valued at $21.55M, representing 0.51% of its reported portfolio and ranking #47.

Has Siren, L.L.C. been buying or selling RAPP?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in RAPP. The position peaked in Q3 2025 at 1.05M shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.